Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.946    0.002 (0.21%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Biopharma Cred. News

BioPharma Credit hails "attractive pipeline" and backs dividend target
27 Sep 2023

BioPharma Credit hails "attractive pipeline" and backs dividend target

(Alliance News) - BioPharma Credit PLC on Wednesday reported soft growth in its net asset value per share for the first half of 2023.

TRADING UPDATES: Anglo Asian to restart Gedabek operations on approval
26 Sep 2023

TRADING UPDATES: Anglo Asian to restart Gedabek operations on approval

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

BioPharma Credit notes liquidity amendments to LumiraDX loan deal
19 Sep 2023

BioPharma Credit notes liquidity amendments to LumiraDX loan deal

(Alliance News) - BioPharma Credit PLC on Tuesday said Lumira DX Investment Ltd announced an amendment on Monday to its loan agreement with BioPharma ...

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS
18 Sep 2023

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

TRADING UPDATES: Byotrol loss widens, Surface Transforms sales grow
31 Jul 2023

TRADING UPDATES: Byotrol loss widens, Surface Transforms sales grow

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

TRADING UPDATES: Andrada raises GBP7.7 million; Ixico signs contract
18 Jul 2023

TRADING UPDATES: Andrada raises GBP7.7 million; Ixico signs contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: